These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28494557)

  • 1. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
    Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
    Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
    World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome.
    Yu P; Zhou Y; Li X
    J Clin Ultrasound; 2022 Nov; 50(9):1368-1372. PubMed ID: 36149806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced Bile Duct Injury - A Short Review.
    Dobreva I; Karagyozov P
    Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced bile duct injury.
    Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
    Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
    Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced bile duct injury: progress and challenges].
    Li DL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):339-344. PubMed ID: 37248973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanishing bile duct syndrome.
    Reau NS; Jensen DM
    Clin Liver Dis; 2008 Feb; 12(1):203-17, x. PubMed ID: 18242505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report.
    Takaki Y; Murahashi M; Honda K; Hirai K
    Medicine (Baltimore); 2022 Nov; 101(45):e31486. PubMed ID: 36397354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal endoscopy in the diagnosis and treatment of biliary liver disease].
    Liang XY; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):690-695. PubMed ID: 36038336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome.
    Conrad MA; Cui J; Lin HC
    J Pediatr; 2016 Feb; 169():313-5.e1. PubMed ID: 26597434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab-Induced Vanishing Bile Duct Syndrome.
    Eiswerth MJ; Heckroth MA; Ismail A; Gondim DD; Kaufman R
    Cureus; 2022 Feb; 14(2):e21940. PubMed ID: 35273881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced cholestasis.
    Velayudham LS; Farrell GC
    Expert Opin Drug Saf; 2003 May; 2(3):287-304. PubMed ID: 12904107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destructive intrahepatic bile duct diseases.
    Desmet VJ
    Recenti Prog Med; 1990 Jun; 81(6):392-8. PubMed ID: 2251446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report.
    Jia Y; Liu L; Deng B; Huang Y; Zhao J; Bai G
    Diagn Pathol; 2022 Jul; 17(1):57. PubMed ID: 35787279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.